References
- Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non- Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002;95:1504-1510 https://doi.org/10.1002/cncr.10851
- Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin 2007;25:867-890 https://doi.org/10.1016/j.ncl.2007.07.002
- DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-123 https://doi.org/10.1056/NEJM200101113440207
- Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109 https://doi.org/10.1007/s00401-007-0243-4
- Faehndrich J, Weidauer S, Pilatus U, Oszvald A, Zanella FE, Hattingen E. Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions. Clin Neuroradiol 2011;21:123-139 https://doi.org/10.1007/s00062-011-0073-6
- Provenzale JM, Mukundan S, Barboriak DP. Diffusionweighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632-649 https://doi.org/10.1148/radiol.2393042031
- Kickingereder P, Wiestler B, Sahm F, et al. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. Radiology 2014;272:843-850 https://doi.org/10.1148/radiol.14132740
- Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394-403 https://doi.org/10.1016/j.ejrad.2005.12.032
- Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338:119-122 https://doi.org/10.1016/S0304-3940(02)01367-8
- Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intraaxial brain tumors. Neuroradiology 2006;48:150-159 https://doi.org/10.1007/s00234-005-0030-7
- Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011;32:984-992 https://doi.org/10.3174/ajnr.A2171
- Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29 https://doi.org/10.1148/radiol.2231010594
- Suh CH, Kim HS, Lee SS, et al. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging. Radiology 2014;272:504-513 https://doi.org/10.1148/radiol.14131895
- Blasel S, Jurcoane A, Bahr O, Weise L, Harter PN, Hattingen E. MR perfusion in and around the contrast-enhancement of primary CNS lymphomas. J Neurooncol 2013;114:127-134 https://doi.org/10.1007/s11060-013-1161-z
- Toh CH, Wei KC, Chang CN, Ng SH, Wong HF. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol 2013;34:1145-1149 https://doi.org/10.3174/ajnr.A3383
- Nakajima S, Okada T, Yamamoto A, et al. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusionweighted MRI. Clin Radiol 2015;70:1393-1399 https://doi.org/10.1016/j.crad.2015.08.004
- Nakajima S, Okada T, Yamamoto A, et al. Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography. Clin Imaging 2015;39:390-395 https://doi.org/10.1016/j.clinimag.2014.12.002
- Xing Z, You RX, Li J, Liu Y, Cao DR. Differentiation of primary central nervous system lymphomas from highgrade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Clin Neuroradiol 2014;24:329-336 https://doi.org/10.1007/s00062-013-0255-5
- Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006;24:817-824 https://doi.org/10.1002/jmri.20707
- Cho SK, Na DG, Ryoo JW, et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002;3:171-179 https://doi.org/10.3348/kjr.2002.3.3.171
- Liao W, Liu Y, Wang X, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217-225 https://doi.org/10.1080/02841850802616752
- Jung SC, Choi SH, Yeom JA, et al. Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods. PLoS One 2013;8:e69323 https://doi.org/10.1371/journal.pone.0069323
- Heye T, Merkle EM, Reiner CS, et al. Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis. Radiology 2013;266:812-821 https://doi.org/10.1148/radiol.12120255
- Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797-803 https://doi.org/10.1148/radiol.2243011014
- Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808-817 https://doi.org/10.1148/radiol.2473070571
- Ma JH, Kim HS, Rim NJ, Kim SH, Cho KG. Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol 2010;31:1699-1706 https://doi.org/10.3174/ajnr.A2161
- Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725 https://doi.org/10.1002/mrm.1910360510
- Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265 https://doi.org/10.1002/mrm.1910140211
- Bjornerud A. The ICE software package: direct coregistration of anatomical and functional datasets using DICOM image geometry information. Proc Hum Brain Mapping 2003;19:1018
- DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845 https://doi.org/10.2307/2531595
- Wesseling P, Ruiter DJ, Burger PC. Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 1997;32:253-265 https://doi.org/10.1023/A:1005746320099
- Bauknecht HC, Romano VC, Rogalla P, et al. Intraand interobserver variability of linear and volumetric measurements of brain metastases using contrastenhanced magnetic resonance imaging. Invest Radiol 2010;45:49-56 https://doi.org/10.1097/RLI.0b013e3181c02ed5
- Kim H, Choi SH, Kim JH, et al. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading. PLoS One 2013;8:e63462 https://doi.org/10.1371/journal.pone.0063462
- Odland A, Server A, Saxhaug C, et al. Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth. Acta Radiol 2015;56:1396-1403 https://doi.org/10.1177/0284185114554822
- Ryoo I, Choi SH, Kim JH, et al. Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles. PLoS One 2013;8:e71704 https://doi.org/10.1371/journal.pone.0071704
Cited by
- Dynamic Susceptibility Contrast (DSC) Perfusion MR in the Prediction of Long-Term Survival of Glioblastomas (GBM): Correlation with MGMT Promoter Methylation and 1p/19q Deletions vol.22, pp.3, 2018, https://doi.org/10.13104/imri.2018.22.3.158
- Correlation and Characteristics of Intravoxel Incoherent Motion and Arterial Spin Labeling Techniques Versus Multiple Parameters Obtained on Dynamic Susceptibility Contrast Perfusion MRI for Brain Tum vol.66, pp.3, 2019, https://doi.org/10.2152/jmi.66.308
- Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram vol.61, pp.9, 2017, https://doi.org/10.1177/0284185119896519